Federal Circuit Summary -
Before Newman, Hughes, and Stoll. Appeal from the United States District Court for the District of Delaware
Summary: Objective indicia of nonobviousness cannot be dismissed merely because all...more
9/14/2018
/ Actavis Inc. ,
Appeals ,
Generic Drugs ,
Hatch-Waxman ,
Investigational New Drug Application (IND) ,
Nonobvious ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Reversal
Federal Circuit Summaries -
Before Newman, Dyk, and Chen. Appeal from the District of Colorado.
Summary: (1) The Federal Circuit’s separate affirmance of a PTAB decision that a patent in suit is invalid renders an...more
5/31/2018
/ Appeals ,
Calculation of Damages ,
Collateral Estoppel ,
Concurrent Litigation ,
Jury Verdicts ,
Mootness ,
Patent Invalidity ,
Patent Royalties ,
Patent Trial and Appeal Board ,
Patent-in-Suit ,
Patents